Global Immunotherapy Drugs Market to reach USD 402.2 billion by 2026.

Global Immunotherapy Drugs Market Size Study, by Type of Drugs (Monoclonal Antibodies, Adult Vaccines, Checkpoint Inhibitors, Interferons Alpha & Beta, Interleukins, Others) by Therapy Area (Cancer, Autoimmune & Inflammatory Diseases, Infectious Diseases, Others) by End-Use (Hospitals, Clinics, Others) by Regional Forecasts 2019-2026
Product Code:  HALDAT_49286296
Chapter 1.	Executive Summary 
1.1.	Market Snapshot
1.2.	Key Trends
1.3.	Global & Segmental Market Estimates & Forecasts, 2016-2026 (USD Billion)
1.3.1.	Immunotherapy Drugs Market, by Type of Drug, 2016-2026 (USD Billion)
1.3.2.	Immunotherapy Drugs Market, by Therapy Area, 2016-2026 (USD Billion)
1.3.3.	Immunotherapy Drugs Market, by End-use, 2016-2026 (USD Billion)
1.3.4.	Immunotherapy Drugs Market, by Region, 2016-2026 (USD Billion)
1.4.	Estimation Methodology
1.5.	Research Assumption
Chapter 2.	Global Immunotherapy Drugs Market Definition and Scope 
2.1.	Objective of the Study
2.2.	Market Definition & Scope
2.2.1.	Industry Evolution
2.2.2.	Scope of the Study
2.3.	Years Considered for the Study
2.4.	Currency Conversion Rates
Chapter 3.	Global Immunotherapy Drugs Market Dynamics	
3.1.	See Saw Analysis
3.1.1.	Market Drivers
3.1.2.	Market Challenges
3.1.3.	Market Opportunities
Chapter 4.	Global Immunotherapy Drugs Market Industry Analysis
4.1.	Porter’s 5 Force Model
4.1.1.	Bargaining Power of Buyers
4.1.2.	Bargaining Power of Suppliers
4.1.3.	Threat of New Entrants
4.1.4.	Threat of Substitutes
4.1.5.	Competitive Rivalry
4.1.6.	Futuristic Approach to Porter’s 5 Force Model
4.2.	PEST Analysis
4.2.1.	Political Scenario
4.2.2.	Economic Scenario
4.2.3.	Social Scenario
4.2.4.	Technological Scenario
4.3.	Key Buying Criteria (On Demand)
4.4.	Regulatory Framework (On Demand)
4.5.	Investment Vs Adoption Scenario (On Demand)
4.6.	Analyst Recommendation & Conclusion
Chapter 5.	Global Immunotherapy Drugs Market, by Type of Drug 
5.1.	Market Snapshot 
5.2.	Market Performance - Potential Model
5.3.	Immunotherapy Drugs Market, Sub Segment Analysis
5.3.1.	  Monoclonal Antibodies     
5.3.1.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
5.3.1.2.	Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
5.3.2.	  Adult Vaccines   
5.3.2.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
5.3.2.2.	Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
5.3.3.	  Checkpoint Inhibitors 
5.3.3.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
5.3.3.2.	Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
5.3.4.	 Interferons Alpha & Beta 
5.3.4.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
5.3.4.2.	Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
5.3.5.	  Interleukins 
5.3.5.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
5.3.5.2.	Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
5.3.6.	 Others Drugs 
5.3.6.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
5.3.6.2.	Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)

Chapter 6.	Global Immunotherapy Drugs Market, by Therapy Area          
6.1.	Market Snapshot 
6.2.	Market Performance - Potential Model
6.3.	Immunotherapy Drugs Market, Sub Segment Analysis
6.3.1.	  Cancer    
6.3.1.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
6.3.1.2.	Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
6.3.2.	  Autoimmune & Inflammatory Diseases 
6.3.2.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
6.3.2.2.	Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
6.3.3.	  Infectious Diseases 
6.3.3.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
6.3.3.2.	Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
6.3.4.	  Other Therapy Areas  
6.3.4.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
6.3.4.2.	Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
Chapter 7.	Global Immunotherapy Drugs Market, by  End-use           
7.1.	Market Snapshot 
7.2.	Market Performance - Potential Model
7.3.	Immunotherapy Drugs Market, Sub Segment Analysis
7.3.1.	   Hospital 
7.3.1.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
7.3.1.2.	Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.3.2.	   Clinics
7.3.2.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
7.3.2.2.	Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.3.3.	    Other End user 
7.3.3.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
7.3.3.2.	Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)

Chapter 8.	Global Immunotherapy Drugs Market, by Regional Analysis
8.1.	Immunotherapy Drugs Market, Regional Market Snapshot (2016-2026)
8.2.	North America Immunotherapy Drugs Market Snapshot
8.2.1.	U.S.
8.2.1.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
8.2.1.2.	 Type of Drug breakdown estimates & forecasts, 2016-2026 (USD Billion) 
8.2.1.3.	 Therapy Area breakdown estimates & forecasts, 2016-2026 (USD Billion)   
8.2.1.4.	End-use breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.2.2.	Canada
8.2.2.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
8.2.2.2.	Type of Drug breakdown estimates & forecasts, 2016-2026 (USD Billion) 
8.2.2.3.	 Therapy Area breakdown estimates & forecasts, 2016-2026 (USD Billion)   
8.2.2.4.	End-use breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.3.	Europe Immunotherapy Drugs Market Snapshot
8.3.1.	U.K. 
8.3.1.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
8.3.1.2.	Type of Drug breakdown estimates & forecasts, 2016-2026 (USD Billion) 
8.3.1.3.	 Therapy Area breakdown estimates & forecasts, 2016-2026 (USD Billion)   
8.3.1.4.	End-use breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.3.2.	Rest of Europe
8.3.2.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
8.3.2.2.	Type of Drug breakdown estimates & forecasts, 2016-2026 (USD Billion) 
8.3.2.3.	 Therapy Area breakdown estimates & forecasts, 2016-2026 (USD Billion)   
8.3.2.4.	End-use breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.4.	Asia Immunotherapy Drugs Market Snapshot
8.4.1.	China 
8.4.1.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
8.4.1.2.	Type of Drug breakdown estimates & forecasts, 2016-2026 (USD Billion) 
8.4.1.3.	 Therapy Area breakdown estimates & forecasts, 2016-2026 (USD Billion)   
8.4.1.4.	End-use breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.4.2.	India 
8.4.2.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
8.4.2.2.	Type of Drug breakdown estimates & forecasts, 2016-2026 (USD Billion) 
8.4.2.3.	 Therapy Area breakdown estimates & forecasts, 2016-2026 (USD Billion)   
8.4.2.4.	End-use breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.4.3.	Japan
8.4.3.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
8.4.3.2.	Type of Drug breakdown estimates & forecasts, 2016-2026 (USD Billion) 
8.4.3.3.	 Therapy Area breakdown estimates & forecasts, 2016-2026 (USD Billion)   
8.4.3.4.	End-use breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.4.4.	Rest of Asia Pacific
8.4.4.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
8.4.4.2.	Type of Drug breakdown estimates & forecasts, 2016-2026 (USD Billion) 
8.4.4.3.	 Therapy Area breakdown estimates & forecasts, 2016-2026 (USD Billion)   
8.4.4.4.	End-use breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.5.	Latin America Immunotherapy Drugs Market Snapshot
8.5.1.	Brazil 
8.5.1.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
8.5.1.2.	Type of Drug breakdown estimates & forecasts, 2016-2026 (USD Billion) 
8.5.1.3.	 Therapy Area breakdown estimates & forecasts, 2016-2026 (USD Billion)   
8.5.1.4.	End-use breakdown estimates & forecasts, 2016-2026 (USD Billion)

8.5.2.	Mexico 
8.5.2.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
8.5.2.2.	Type of Drug breakdown estimates & forecasts, 2016-2026 (USD Billion) 
8.5.2.3.	 Therapy Area breakdown estimates & forecasts, 2016-2026 (USD Billion)   
8.5.2.4.	End-use breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.6.	Rest of The World 
8.6.1.	Middle East and Africa
8.6.1.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
8.6.1.2.	Type of Drug breakdown estimates & forecasts, 2016-2026 (USD Billion) 
8.6.1.3.	 Therapy Area breakdown estimates & forecasts, 2016-2026 (USD Billion)   
8.6.1.4.	End-use breakdown estimates & forecasts, 2016-2026 (USD Billion)
Chapter 9.	Competitive Intelligence
9.1.	Company Market Share (Subject to Data Availability)
9.2.	Top Market Strategies
9.3.	Company Profiles
9.3.1.	  F.Hoffmann-LA Roche AG
9.3.1.1.	Overview
9.3.1.2.	Financial (Subject to Data Availability)
9.3.1.3.	Product Summary
9.3.1.4.	Recent Developments
9.3.2.	 Merck & Co., Inc.
9.3.3.	Novartis International AG 
9.3.4.	Johnson & Johnson (A Parent Company of Jannssen Biotech, Inc.)
9.3.5.	GlaxoSmithKline PLC 
9.3.6.	Amgen Inc. 
9.3.7.	AbbVie 
9.3.8.	AstraZeneca 
9.3.9.	Bristol-Mysers Squibb 
9.3.10.	ELI Lilly & Company 
Chapter 10.	Research Process
10.1.	Research Process
10.1.1.	Data Mining
10.1.2.	Analysis
10.1.3.	Market Estimation
10.1.4.	Validation
10.1.5.	Publishing
10.1.6.	Research Assumption

List of Tables
TABLE 1.	LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL IMMUNOTHERAPY DRUGS MARKET
TABLE 2.	LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL IMMUNOTHERAPY DRUGS MARKET
TABLE 3.	GLOBAL IMMUNOTHERAPY DRUGS MARKET, REPORT SCOPE
TABLE 4.	YEARS CONSIDERED FOR THE STUDY
TABLE 5.	EXCHANGE RATES CONSIDERED
TABLE 6.	GLOBAL IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY REGION 2016-2026 (USD BILLION)
TABLE 7.	GLOBAL IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY TYPE OF DRUG 2016-2026 (USD BILLION)
TABLE 8.	GLOBAL IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY THERAPY AREA 2016-2026 (USD BILLION)
TABLE 9.	GLOBAL IMMUNOTHERAPY DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 10.	GLOBAL IMMUNOTHERAPY DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 11.	GLOBAL IMMUNOTHERAPY DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 12.	GLOBAL IMMUNOTHERAPY DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 13.	GLOBAL IMMUNOTHERAPY DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 14.	GLOBAL IMMUNOTHERAPY DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 15.	GLOBAL IMMUNOTHERAPY DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 16.	GLOBAL IMMUNOTHERAPY DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION) 
TABLE 17.	GLOBAL IMMUNOTHERAPY DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 18.	GLOBAL IMMUNOTHERAPY DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION) 
TABLE 19.	GLOBAL IMMUNOTHERAPY DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 20.	GLOBAL IMMUNOTHERAPY DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION) 
TABLE 21.	GLOBAL IMMUNOTHERAPY DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 22.	GLOBAL IMMUNOTHERAPY DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION) 
TABLE 23.	GLOBAL IMMUNOTHERAPY DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 24.	GLOBAL IMMUNOTHERAPY DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION) 
TABLE 25.	GLOBAL IMMUNOTHERAPY DRUGS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 26.	GLOBAL IMMUNOTHERAPY DRUGS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION) 
TABLE 27.	U.S. IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 28.	U.S. IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 29.	U.S. IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 30.	CANADA IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 31.	CANADA IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 32.	CANADA IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 33.	UK IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 34.	UK IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 35.	UK IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 36.	GERMANY IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 37.	GERMANY IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 38.	GERMANY IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 39.	ROE IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 40.	ROE IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 41.	ROE IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 42.	CHINA IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 43.	CHINA IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 44.	CHINA IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 45.	INDIA IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 46.	INDIA IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 47.	INDIA IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 48.	JAPAN IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 49.	JAPAN IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 50.	JAPAN IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 51.	ROAPAC IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 52.	ROAPAC IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 53.	ROAPAC IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 54.	BRAZIL IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 55.	BRAZIL IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 56.	BRAZIL IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 57.	MEXICO IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 58.	MEXICO IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 59.	MEXICO IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 60.	ROLA IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 61.	ROLA IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 62.	ROLA IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 63.	ROW IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 64.	ROW IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 65.	ROW IMMUNOTHERAPY DRUGS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

List of Figures
FIG 1.	GLOBAL IMMUNOTHERAPY DRUGS MARKET, RESEARCH METHODOLOGY
FIG 2.	GLOBAL IMMUNOTHERAPY DRUGS MARKET, MARKET ESTIMATION TECHNIQUES
FIG 3.	GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
FIG 4.	GLOBAL IMMUNOTHERAPY DRUGS MARKET, KEY TRENDS 2017
FIG 5.	GLOBAL IMMUNOTHERAPY DRUGS MARKET, GROWTH PROSPECTS 2018-2026
FIG 6.	GLOBAL IMMUNOTHERAPY DRUGS MARKET, PORTERS 5 FORCE MODEL
FIG 7.	GLOBAL IMMUNOTHERAPY DRUGS MARKET, PEST ANALYSIS
FIG 8.	GLOBAL IMMUNOTHERAPY DRUGS MARKET, VALUE CHAIN ANALYSIS
FIG 9.	GLOBAL IMMUNOTHERAPY DRUGS MARKET BY SEGMENT, 7 (USD BILLION)
FIG 10.	GLOBAL IMMUNOTHERAPY DRUGS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 11.	GLOBAL IMMUNOTHERAPY DRUGS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 12.	GLOBAL IMMUNOTHERAPY DRUGS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 13.	GLOBAL IMMUNOTHERAPY DRUGS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 14.	GLOBAL IMMUNOTHERAPY DRUGS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 15.	GLOBAL IMMUNOTHERAPY DRUGS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 16.	GLOBAL IMMUNOTHERAPY DRUGS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 17.	GLOBAL IMMUNOTHERAPY DRUGS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 18.	GLOBAL IMMUNOTHERAPY DRUGS MARKET, REGIONAL SNAPSHOT 2016 & 2026
FIG 19.	NORTH AMERICA IMMUNOTHERAPY DRUGS MARKET 2016 & 2026 (USD BILLION)
FIG 20.	EUROPE IMMUNOTHERAPY DRUGS MARKET 2016 & 2026 (USD BILLION)
FIG 21.	ASIA PACIFIC IMMUNOTHERAPY DRUGS MARKET 2016 & 2026 (USD BILLION)
FIG 22.	LATIN AMERICA IMMUNOTHERAPY DRUGS MARKET 2016 & 2026 (USD BILLION)
FIG 23.	GLOBAL IMMUNOTHERAPY DRUGS MARKET, COMPANY MARKET SHARE ANALYSIS (2017)

Global Immunotherapy Drugs Market valued approximately USD 141 billion in 2018 is anticipated to grow with a healthy growth rate of more than 14.0% over the forecast period 2019-2026. Faster drug approval processes, rising prevalence of life style-oriented diseases, and rising adoption of targeted therapies are the primary growth drivers for global immunotherapy drugs market. However, the market growth is restricted by the high cost of immunotherapy treatment.
Global Immunotherapy market is segmented by type of drugs, therapy area and end-use. Based on therapy area the market is segmented into cancer, autoimmune & inflammatory diseases, infectious diseases, and others. Among these, currently the market is dominated by cancer segment which is anticipated to account for 33% revenue share in 2016. The cancer segment will continue to dominate over the forecast period and is also anticipated to register the highest growth over the forecast period. Increasing prevalence of cancer and rising adoption of immunotherapy for cancer treatment is driving the market growth.
Major market player included in this report are:
F.Hoffmann
Merck & Co., Inc.
Novartis International AG
Johnson & Johnson (A Parent Company of Jannssen Biotech, Inc.)
Glaxosmithkline PLC
Amgen Inc.
Abbvie, Amstrazeneca
Bristol-Mysers Squibb
ELI Lilly & Company

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type of Drugs:

Monoclonal Antibodies
Adult Vaccines
Preventive Vaccines
Therapeutic Vaccines
Checkpoint Inhibitors
Interferons Alpha & Beta
Interleukins
Other Drugs

By Therapy Area:

Cancer
Autoimmune & Inflammatory Diseases
Infectious Diseases
Other Therapy Area

By End-Use:

Hospitals
Clinics
Other End Users

By Regions:

North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2016, 2017
Base year – 2018
Forecast period – 2019 to 2026

Target Audience of the Global Immunotherapy Drugs Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors


We offer 10% free customization including country-level data, niche applications and competitive landscape with every report. This also includes a 30 minute free analyst discussion post report purchase.

Full Name*

Business Email* (Please avoid generic email IDs such as gmail, yahoo)

Phone* (Please Affix Country Code)

Need specific market information? To get a customized report, please share your exact research requirements.



Loading…